Tirzepatide
100% delivery
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
Tirzepatide
Tirzepatide · TZP · TIRZ

Tirzepatide is a synthetic 39-amino-acid dual-receptor agonist peptide targeting GIP and GLP-1 receptors for laboratory research.
Overview
Tirzepatide is a dual receptor agonist acting at the GIP and GLP-1 receptors, studied as a GIP-sequence analog in peptide research.
Peptides Duo offers tirzepatide across a wide strength range with scalable quantities, competitive lead times and reliable global supply.
What is Tirzepatide?
Tirzepatide is a 39-amino-acid modified peptide based on the GIP sequence with aminoisobutyric acid (Aib) in positions 2 and 13, a C-terminal amide, and a Lys residue at position 20 that is attached to 1,20-eicosanedioic acid via a linker. The molecular weight is 4813.53 Da and the empirical formula is C225H348N48O68.
Characterization
Each batch is HPLC-purified and mass-confirmed, with identity, purity and net peptide content documented on the COA.
Key Highlights
- Dual-receptor agonist: GLP-1R / GIPR
- ≥99% purity verified by HPLC & Mass Spectrometry
- Lyophilized powder; custom labeling and packaging available
- Third-party tested, research-grade raw material
- For laboratory research use only
Safety & Side Effects
Tirzepatide is a synthetic 39-amino-acid dual-receptor agonist peptide targeting GIP and GLP-1 receptors for laboratory research. When used in research, Tirzepatide should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.
Published tirzepatide side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for metabolic regulation and energy expenditure readouts and any off-target effects relevant to the compound’s mechanism when designing a study.
For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.
Dosage & Protocol
There is no standardized human dosage for Tirzepatide; it is supplied strictly for laboratory research. Reported tirzepatide dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.
Research protocols typically document tirzepatide dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS 2023788-19-2, molecular formula C225H348N48O68, molecular weight 4813.53 g/mol). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.
Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.
Comparison
| Peptide | ReceptorsCore | Characteristic |
|---|---|---|
| Tirzepatide | GLP-1R+GIPR | Dual-receptor metabolic peptide |
| Retatrutide | GLP-1R+GIPR+GCGR | Triple agonist for metabolic research |
| Semaglutide | GLP-1R | Single GLP-1 receptor agonist |
How to Order
Enquiry
Send strength and quantity for a quote.
Quotation
Price, lead time and specification confirmed.
QC & COA
HPLC/LC-MS tested; COA issued.
Delivery
Tracked worldwide shipping.
Specifications
| Product name | Tirzepatide |
|---|---|
| Product code | T5 |
| Specification | 5mg*10vials |
| CAS number | 2023788-19-2 |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813.53 g/mol |
| Purity | ≥99% (subject to batch COA) |
| Appearance | White lyophilized powder |
| Packaging | 5–120 mg × 10 vials |
Applications
Packaging & Shipping
Available pack sizes
Shipping
Storage & Handling
Store lyophilized at −20 °C away from light and moisture. Warm to room temperature before opening; refrigerate after reconstitution and minimize freeze–thaw cycles.
Product Information Q&A
Can I view the Certificate of Analysis before purchase?
Corresponding batch COA documents are available upon request.
What does “Research Use Only” mean?
This peptide is for laboratory research only, not for human or veterinary administration.
How should Tirzepatide be shipped and stored?
Shipped as lyophilized powder. Store dry powder at -20°C away from light and humidity.
Additional information
| Specification | 5mg*10vials, 10mg*10vials, 15mg*10vials, 20mg*10vials, 30mg*10vials, 40mg*10vials, 50mg*10vials, 60mg*10vials, 80mg*10vials(10ml), 120mg*10vials(10ml) |
|---|






